End of the beginning and public health pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine
dc.contributor.author | Ozdemir V. | |
dc.contributor.author | Fisher E. | |
dc.contributor.author | Dove E.S. | |
dc.contributor.author | Burton H. | |
dc.contributor.author | Wright G.E.B. | |
dc.contributor.author | Masellis M. | |
dc.contributor.author | Warnich L. | |
dc.date.accessioned | 2012-05-17T09:01:00Z | |
dc.date.available | 2012-05-17T09:01:00Z | |
dc.date.issued | 2012 | |
dc.description.abstract | [No abstract available] | |
dc.identifier.citation | Current Pharmacogenomics and Personalized Medicine | |
dc.identifier.citation | 10 | |
dc.identifier.citation | 1 | |
dc.identifier.citation | 1 | |
dc.identifier.citation | 6 | |
dc.identifier.issn | 18756921 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/21085 | |
dc.title | End of the beginning and public health pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine | |
dc.type | Editorial |